Breadth and visibility of children's lower limb chronic musculoskeletal pain: a scoping review.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

To identify the types of conditions reported in peer-reviewed literature that result in chronic musculoskeletal lower limb pain in children and adolescents and explore the alignment of these conditions with the chronic pain reporting codes indexed in the International Classification of Diseases 11th Revision (ICD-11). This scoping review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Five electronic databases were searched (Medline, EMBASE, PsycINFO, CINAHL and the Cochrane Library). Articles involving children and adolescents under 18 years and reporting on chronic musculoskeletal pain of the lower limb were included. We assigned an ICD-11 code to each condition based on details reported in the study. We recorded whether any of the presenting conditions were linked to an ICD-11 chronic pain manifestation code. From 12 343 records, 418 papers were included. There were 124 unique conditions associated with chronic lower limb pain, the most commonly reported being chronic widespread musculoskeletal pain (24 studies) and juvenile idiopathic arthritis (26 studies). Only 11.1% of presenting conditions were linked to an ICD-11 chronic pain manifestation code. Most presenting conditions associated with chronic pain in the lower limb do not have a chronic pain manifestation code in the new global standard for recording health information. This means chronic pain associated with common lower limb conditions may remain invisible in global statistics.

Identifiants

pubmed: 39477277
pii: bmjopen-2023-082801
doi: 10.1136/bmjopen-2023-082801
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e082801

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Emre Ilhan (E)

Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.

Luke Davies (L)

Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.

Verity Pacey (V)

Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.

Mitchell Smith (M)

School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.

Jane Munro (J)

Department of Medicine, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Craig Munns (C)

Faculty of Medicine and Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
Department of Endocrinology and Diabetes, Queensland Children's Hospital, Brisbane, Queensland, Australia.

Elizabeth Sturgiss (E)

School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.

Nicole Williams (N)

Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
Department of Orthopaedic Surgery, Women's and Children's Hospital Adelaide, North Adelaide, South Australia, Australia.

Louise Tofts (L)

Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.

Vance Locke (V)

Western Kids Health, Shenton Park, Western Australia, Australia.

Terry Haines (T)

School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.

Sue E Brennan (SE)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Stephen Maloney (S)

School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.

Mitchell N Sarkies (MN)

Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Ornella Clavisi (O)

Musculoskeletal Australia, Melbourne, Victoria, Australia.

Dan Miles (D)

Australian Podiatry Association, Melbourne, Victoria, Australia.

Lisa Nissen (L)

Centre for the Business and Economics of Health, The University of Queensland, Brisbane, Queensland, Australia.

Cylie Williams (C)

School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia cylie.williams@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH